WallStreetZenWallStreetZen

NYSE: XRN
Chiron Real Estate Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for XRN

Based on 2 analysts offering 12 month price targets for Chiron Real Estate Inc

Min Forecast
$40.00+7.53%
Avg Forecast
$40.50+8.87%
Max Forecast
$41.00+10.22%

Should I buy or sell XRN stock?

Based on 2 analysts offering ratings for Chiron Real Estate Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although XRN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates XRN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their XRN stock forecasts and price targets.

XRN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-10-13

1 of 1

Forecast return on equity

Is XRN forecast to generate an efficient return?

Company
N/A
Industry
6.11%
Market
261.19%

Forecast return on assets

Is XRN forecast to generate an efficient return on assets?

Company
N/A
Industry
3.49%

XRN earnings per share forecast

What is XRN's earnings per share in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.23
Avg 2 year Forecast
$0.41

XRN revenue forecast

What is XRN's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$153.9M+6.15%
Avg 2 year Forecast
$159.4M+9.95%
Avg 3 year Forecast
$161.5M+11.38%
XRN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XRN revenue growth forecast

How is XRN forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
4.49%
Industry
11.72%
Market
65.38%
XRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XRN vs Healthcare Facility REIT Stocks

TickerPricePrice TargetUp/downsideConsensus
XRN$37.20$40.50+8.87%Buy
CHCT$16.82$18.33+9.00%Buy
UHT$44.09N/AN/A
STRW$12.96$14.00+8.02%Strong Buy
SILA$26.39$26.00-1.48%Buy
View Top Healthcare Facility REIT Stocks

Chiron Real Estate Stock Forecast FAQ

Is Chiron Real Estate Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: XRN) stock is to Buy XRN stock.

Out of 2 analysts, 0 (0%) are recommending XRN as a Strong Buy, 1 (50%) are recommending XRN as a Buy, 1 (50%) are recommending XRN as a Hold, 0 (0%) are recommending XRN as a Sell, and 0 (0%) are recommending XRN as a Strong Sell.

If you're new to stock investing, here's how to buy Chiron Real Estate stock.

What is XRN's earnings growth forecast for 2026-2027?

(NYSE: XRN) Chiron Real Estate's forecast annual earnings growth rate of N/A is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast earnings growth rate of 41.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 111.87%.

Chiron Real Estate's earnings in 2026 is -$3,323,000.On average, 5 Wall Street analysts forecast XRN's earnings for 2026 to be $3,145,366, with the lowest XRN earnings forecast at $788,353, and the highest XRN earnings forecast at $5,631,090.

In 2027, XRN is forecast to generate $5,470,202 in earnings, with the lowest earnings forecast at $5,255,684 and the highest earnings forecast at $5,631,090.

What is XRN's revenue growth forecast for 2026-2028?

(NYSE: XRN) Chiron Real Estate's forecast annual revenue growth rate of 4.49% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 11.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 65.38%.

Chiron Real Estate's revenue in 2026 is $144,972,000.On average, 9 Wall Street analysts forecast XRN's revenue for 2026 to be $2,063,258,323, with the lowest XRN revenue forecast at $1,957,742,415, and the highest XRN revenue forecast at $2,167,031,274. On average, 6 Wall Street analysts forecast XRN's revenue for 2027 to be $2,137,132,865, with the lowest XRN revenue forecast at $1,976,110,496, and the highest XRN revenue forecast at $2,331,941,777.

In 2028, XRN is forecast to generate $2,164,886,096 in revenue, with the lowest revenue forecast at $2,051,057,627 and the highest revenue forecast at $2,259,676,117.

What is XRN's forecast return on assets (ROA) for 2026-2028?

(NYSE: XRN) forecast ROA is N/A, which is lower than the forecast US REIT - Healthcare Facilities industry average of 3.49%.

What is XRN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year XRN price target, the average XRN price target is $40.50, with the highest XRN stock price forecast at $41.00 and the lowest XRN stock price forecast at $40.00.

On average, Wall Street analysts predict that Chiron Real Estate's share price could reach $40.50 by Nov 11, 2026. The average Chiron Real Estate stock price prediction forecasts a potential upside of 8.87% from the current XRN share price of $37.20.

What is XRN's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: XRN) Chiron Real Estate's current Earnings Per Share (EPS) is -$0.25. On average, analysts forecast that XRN's EPS will be $0.23 for 2026, with the lowest EPS forecast at $0.06, and the highest EPS forecast at $0.42. In 2027, XRN's EPS is forecast to hit $0.41 (min: $0.39, max: $0.42).

What is XRN's forecast return on equity (ROE) for 2026-2028?

(NYSE: XRN) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.